seribantumab
elevation oncology
['solid tumor', 'crest', 'seribantumab']
#cedarssinaicancer at #asco22. dr. karen reckamp is co-author on crestone: initial efficacy and safety of seribantumab in solid tumors harboring nrg1 fusions being presented at 9:45am. 
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.